3P Innovation is an engineering company with a reputation for providing innovative solutions to major pharmaceutical and medical companies, by providing customers with a range of services including high specification manufacturing equipment, special purpose and custom machinery.
4P Therapeutics develops drug delivery technologies and therapeutics, from preclinical testing to clinical manufacturing and early clinical (Phase I/II), with a focus on transdermal products for currently injected compounds, including biologics. 4P is a subsidiary of Nutriband, Inc.
Aardex Group provides digital solutions to measure and manage medication adherence, including digital solutions for adherence-enhancing strategies in clinical trials, research settings and professional healthcare systems, to enhance digital therapeutics and patient empowerment.
Abzena provides proprietary technologies and complementary solutions to organisations involved in the development of biopharmaceutical products. Services and technologies with applications within the drug delivery field include antibody-drug conjugates and PEGylation.
ABITEC's pharmaceutical division develops and manufactures highly functional and reproducible, monograph-compliant lipid-based excipients for drug delivery applications, to enhance the bioavailability of poorly water-soluble and poorly permeable APIs, across multiple delivery routes.
ACG is one of the largest manufacturer of empty hard capsules in the world, offering a complete range of solutions beginning with empty capsules, granulation and coating, capsule filling, tabletting, packaging films, blister packing and carton packing, to end-of-line solutions.
Accu-Break Pharmaceuticals has invented, developed and patented a suite of novel Accu-Break technologies that enable pharmaceutical tablets to be made that can be subdivided by hand into accurate partial doses with the intent of making it easier and safer for patients to adjust their dose.
Adare Pharmaceuticals is a technology-driven CDMO providing product development through to commercial manufacturing expertise focused on oral dosage forms. Adare’s proprietary technology portfolio encompasses ODT’s, taste masking and customised drug release.
Adhesives Research develops adhesive, polymer, and film solutions, including transdermal adhesive components, and drug delivery platform technologies for pharma. It has 50 years of experience in custom polymer synthesis, adhesive formulation, materials science, and flexible manufacturing.
Advanced Catheter Therapies is developing a portfolio of innovative catheter technologies targeting vascular disease, including the Occlusion Perfusion Catheter™ (OPC), an innovative device that can target high concentrations of drug to precisely defined locations.
Adherium is a respiratory eHealth company focused on medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its Hailie® sensor technology and cloud-based data platform provide real-time feedback on patients' use of inhaled medication.
Advanex Europe is the European Headquarters of the Advanex Group, a global corporation specialising in precision engineering solutions, in particular metal and plastic components, springs and assemblies, with applications in inhalable and injectble drug delivery devices.
Aerami Therapeutics is focused on the development of inhaled therapeutics for cardiopulmonary and cardiometabolic diseases, including using its proprietary hand-held, electronic, connected, vibrating-mesh nebuliser, AFINA™.
AeroDrug, located on the University François Rabelais campus, is the aerosol R&D department of Diffusion Technique Française (DTF). Aerodrug develops and designs nebulisers for lower & upper airway delivery. It undertakes development projects for partner organisations.
Aero Pump manufactures high-precision spray pumps and dropper systems for the pharma and healthcare industries, focused on innovative, multi-functional design. They are widely used in the ophthalmic, nasal, buccal and topical fields, suitable for preserved and preservative-free formulations.
Aktiv Pharma Group is a specialty pharma company developing, manufacturing and commercialising sterile injectable products in a portfolio of proprietary, value-added, glass-free, prefilled delivery systems, including its glass-free autoinjector, ARIA.
Alcon develops and manufactures medicines and devices for eye care across four therapeutic areas: glaucoma, cataract & refractive error, retinal, and external disease. Ocular drug delivery R&D represents a significant part of the company's approximately US$1 billion annual R&D spend.
Alliance to Zero is a non-profit membership association for pharma and biotech supply chain companies that facilitates the transition of the pharma sector to compliance with net-zero emissions. It involves, connects and co-ordinates suppliers, pharma companies, manufacturers and service providers.
Altaviz develops and manufactures innovative, high-perfomance platform technologies and specialises in next-generation, gas-powered devices, including for injectable and drug delivery, ophthalmic applications, and for implants.
Altus Drug Development is a drug development company that specialises in value-added medicines. The company's patented drug delivery technologies include abuse-deterrent formulations, breakable controlled release tablets and formulations for insoluble drugs.
Amiko provides hardware-enabled, AI-powered digital medicines. Its first product, Respiro, a digital medicine platform that combines connected inhaler sensors, apps, and data analytics to upgrade respiratory care, has been used in clinical studies and more than 30 commercial programmes across Europe.
ANSYS, Inc, is an engineering simulation software company offering finite element analysis, CFD, electronics, embedded software and design optimisation. Its products have broad applications across drug delivery, in, for example, inhalation R&D to predict powder and aerosol behaviour.
Aprecia uses 3DP technology for commercial-scale, pharmaceutical manufacturing. Its 3DP technology includes a multipatented binder-jetting manufacturing system, allowing for both open-bed and in-cavity printing. Its ZipDose technology platform creates rapidly disintegrating oral dosage forms.
Aptar Pharma provides drug delivery systems, components and services globally. Products include: nasal spray pumps, MDI valves, dose indicators & counters, DPIs, electronic / connected devices, eye-droppers, elastomeric components (for injectable delivery devices), and a two-step autoinjector.
Arthur D. Little is a management consultancy that links strategy, innovation and transformation in technology-intensive and converging industries. Its consultants have practical industry experience. The company was founded in 1886 and has a global presence.
ARx focuses on drug-containing dissolvable film technology and transdermal patches, including oral thin film, mucosal thin film, sublingual drug delivery, and buccal drug delivery, as well as transdermal patch dosage forms. It partners with both generic and branded drug companies.
AssistRx offers software products that aim to increase speed to therapy simplifying the steps to getting patients the therapy they need, connecting the disparate parts of the speciality treatment ecosystem, and delivering the insights needed to improve delivery of care and patient adherence.
AstraZeneca amongst the world's 20 largest pharmaceutical companies by revenue. Numerous products across AstraZeneca's large and varied pharmaceutical product pipeline and portfolio incorporate proprietary and in-licensed drug delivery devices and formulation technologies.
ATS Automation develops and manufactures automation solutions across a variety of industries. In the pharmaceutical sector, the company's offering includes lab, pilot-scale and production-scale automation solutions. ATS has experience working with cleanroom environments.
Avery Dennison's line of dedicated pharmaceutical labels has been developed to meet the highest requirements of the sector, which presents many packaging and labelling challenges; these include security, container size, harsh environments, and stringent regulation.
Avery Dennison Medical (previously Vancive), has >40 years' expertise in materials science and adhesive chemistries for medical applications. It offers innovative solutions including a large portfolio of pressure-sensitive adhesive products, to medical device OEMs and converters.
Battelle, one of the world’s largest independent, non-profit R&D organisations, focuses its contract research efforts on three areas: health, national security & environment. Its involvement in drug delivery goes back to the 1990s – main areas of focus are: injectors, patch pumps and inhalation.
Baumann Group manufacturers springs and stampings and has a dedicated, ISO13485-certified medical division to addresses the unique needs of the medical and pharmaceutical industry. The division designs and manufactures springs for drug delivery devices such as syringes, autoinjectors and inhalers.
BioPharma Solutions, a business unit of Baxter, provides contract manufacturing form/fill/finish for injectables. The company has >85 years of experience and offers sterile dosage forms including prefilled syringes, liquid vials, lyophilised vials, cartridges, and diluents for reconstitution.
BD is a large, diverse, global medical technology company. Its Medical-Pharmaceutical Systems division is the world's largest syringe manufacturer. It offers prefillable syringes, self-injection systems, safety and shielding solutions, and needle technologies and associated pharma services.
Berry Global Healthcare, a division of non-woven, rigid, and flexible products company Berry Global, offers a wide number of specialisations in drug administration, including oral, nasal, pulmonary and ophthalmic, as well as an extensive range of pharmaceutical packaging.
Bespak by Recipharm supplies pulmonary and nasal delivery devices, valves and actuators, injectable devices and medical check valves into major markets. As a high-volume manufacturer, each year it moulds around 2.6 billion components which are assembled into approximately 550 million devices.
Bexson Biomedical is developing ketamine for pain management and mental health disorders, and applying a proprietary delivery system to several psychedelic and non-psychedelic compounds. In 2020, it partnered with Stevanato for the development of ketamine in a wearable subcutaneous injector.
Beyond Air is developing a nitric oxide (NO) generator and drug delivery system, LungFit™ that uses NO generated from ambient air to deliver precise amounts of NO to the lungs for the potential treatment of a variety of pulmonary diseases. The LungFit™ delivery system can generate up to 400 ppm of NO.
Biocorp is an expert in connectivity but develops and manufactures both connected and non-connected injectable drug delivery devices. In addition to its own connected delivery devices it also offers add-ons for existing respiratory and parenteral drug delivery systems.
BiologIC Technologies is developing a combination of digital biology and digital hardware with the aim of enabling the next wave of laboratory automation, including applications in advanced cell therapy manufacturing, that will drive the democratisation of personalised medicine.
Boehringer Ingelheim is a top-20 pharma company by revenues with interests in pharmaceuticals, animal health and biopharma contract manufacturing. Key therapeutic areas are respiratory, metabolism, immunology, oncology and CNS. It has a proprietary soft-mist inhaler, Respimat.
Bora Pharmaceutical CDMO develops prescription and OTC products from late-phase clinical through to commercial manufacturing and packaging, focusing on complex oral solid dosage (tablet & capsules); liquids (solutions, suspensions, and nasal sprays); and semi-solids (cream & gels).
Bormioli Pharma is a primary glass and plastic packaging manufacturer serving the pharmaceutical, biopharmaceutical and nutraceutical markets. The company's products include dual-chamber systems, and are targeted towards drugs for oral, parenteral, ophthalmic and nasal delivery
In January 2020, the Bosch Packaging Technology division was acquired by CVC Capital Partners and rebranded as Syntegon. The company provides process technology and packaging solutions. Its portfolio includes single units, complete lines and integrated systems for manufacturing and processing liquids and solids; also process technology, primary packaging and inspection technology.
This company is inactive
The Buchanan Ocular Therapeutics Unit conducts scientific research into new treatments - be they pharmaceutical-, cell- or technology-based - for eye diseases (ocular therapeutics). Research focuses on developing drug-releasing implants for the eye and evaluating new treatments.
Cambridge Consultants is a large product development engineering and technology consultancy with significant interests, expertise and track record in drug delivery, including respiratory (MDIs, DPIs, nebulisers), parenteral (pens, autoinjectors, wearables), and connectivity.
Cambridge Design Partnership is an independent innovation partner that designs and engineers drug delivery systems, as well as diagnostics, surgical equipment, and other health-related products. It has completed >1,000 product development assignments for business around the world.
Cambridge Pharma specialises in pharma services, sterile fill-finish batches of 100–10,000 units for a range of presentations including its own primary containers, as well as syringes, cartridges and vials. The company works with a wide variety of formulations including small molecules and biologics.
Canè SpA develops and manufactures ambulatory infusion pumps, specialist syringes and related consumables and accessories. Its Crono line of miniature pumps deliver drug volumes ranging from 10 mL to 100 mL, and may be worn without impacting patients’ normal daily routine.
Cardiff University, ranked 2nd for the impact of its research in the UK, and a top five UK university for research excellence, researches technological and biological aspects of drug and gene delivery, including transcutaneous, pulmonary and intestinal delivery, and crossing the blood brain barrier.
Catalent's offering in the field of drug delivery is vast and spans oral, inhalable and injectable routes, and others. It is a development, delivery and supply partner with a large range of solutions for small molecules and biotherapeutics, including numerous proprietary drug delivery technologies.
CCBio is a medical device designer and manufacturer with core competencies including tooling, moulding, assembly, validation, R&D, RA and pharmaceutical testing, all in-house. It offers combination products, medical devices and medical containers to pharma partners and, ultimately, patients.
Celanese's drug delivery offering spans both device and formulation applications. Its high-performance engineering thermoplastics have applications in injection pens, inhalers and syringes requiring robust and reliable materials. Its EVA polymers are used as controlled-release excipients.
Ceramisphere Health develops transdermal patches for the delivery of analgesics with an emphasis on controlled drugs for pain-relief. Its transdermal patches have application for the delivery of small and large therapeutic molecules for human and veterinary health.
Chiesi is a multinational pharma company, active in the development of pulmonary delivery technologies for application in its product pipeline. The Modulite formulation technology is for pMDI spray solutions. Chiesi has also introduced into the market a DPI, which is also able to deliver extra-fine particles.
Clariant Masterbatches, part of Clariant International Ltd, supplies colour and additive concentrates and performance solutions for plastics. There are numerous applications, which require specialist expertise and regulatory knowledge, in drug delivery devices such inhalers and injectors.
Coalesce Product Development is now the Sandoz Device Development Centre having been acquired by Sandoz (Novartis) in 2022. It developed medical and drug delivery devices for respiratory markets with expertise in mechanical engineering, electronics, industrial design, and human factors.
This company is inactive
Chimera Consulting provides technical, regulatory affairs, quality assurance and compliance consulting services to companies that develop, manufacture and market drugs, biologics, medical devices, and in particular combination products such as drug delivery systems and medicated devices.
Founded by researchers at Rice University, Cognita Labs is developing connected respiratory diagnostics and monitoring technology. Its CapMedic™ device and cloud platform turn regular MDIs into smart inhalers that provide feedback on inhaler technique, real-time cues and delivered dose estimates.
Colorcon designs, and provides technical support for, advanced coating systems, modified release technologies and functional excipients to pharma and nutritional supplement companies for solid oral dosage forms. It is a multinational company with operations throughout the world.
Congruence Medical Solutions designs, develops and supplies device platforms that optimise the potential of injectable drugs with emerging and hard-to address delivery needs. It offers solutions for microlitre dosing, viscous drug delivery, multi-dosing, variable dosing and minimising drug waste.
Copley Scientific supplies a range of equipment, software and services for inhaled product testing for every stage of development and manufacture, of both innovator and generic products, topical and systemic. It is also a provider of test instrumentation for other dosage forms.
Core Human Factors is a human factors and usability engineering consultancy covering consumer, industrial, and healthcare-related products. It offers an extensive range of services for medical device development including: usability testing, regulatory guidance, contextual enquiry, and validation testing.
CoreRx is a CDMO providing services to the pharmaceutical and biotechnology industries for the development, manufacturing and testing of solid, liquid and semi-solid dosage forms. The application of processes and technologies for improving drug delivery features strongly.
Coto Technology designs and manufactures advanced, high-reliability switching and magnetic sensing solutions sold into the medical, automotive, data acquisition, instrumentation, process control, telecommunications, automatic test equipment and security markets.
CounterAct is developing a nasal delivery device for naloxone in the treatment of opioid overdose. It has completed its pre-IND meeting with the US FDA, has a 505(B)(2) regulatory path mapped, has a US patent granted and has filed international non-provisional patents.
Covestro LLC is part of the global Covestro business, a major global manufacturer of high-quality polymer materials and components. With its innovative products, processes and methods, the company helps enhance sustainability and quality of life in many areas and across numerous industries.
Credence MedSystems' is developing its Companion family of syringes, which includes proprietary needle-retraction technology in Staked-Needle and Luer formats, and its portfolio has expanded to include Dual Chamber configurations, metered-dose applications and other devices.
Cristal Therapeutics is a clinical-stage business with a pipeline of proprietary drug candidates based on its nanoparticle technology platform, CriPec®, for enhancing and enabling the targeted delivery of injectables in various therapeutic areas including oncology.
Crossject combines well known drugs with an innovative mode of injection, its prefilled and single-use needle-free injection system, ZENEO, which can be tailored to deliver drugs intradermally, subcutaneously and intramuscularly. The company's focus is on products (e.g. adrenaline) for use in emergencies.
CSL Behring develops therapies, often derived from human plasma, to treat rare and serious conditions. The company's interest in seeking the best drug delivery systems arises because many of its products need to be injected, and are for chronic conditions requiring treatment for life.
CURE Pharmaceutical is a drug delivery and development company. Its proprietary technology, CUREfilm™, is a thin film platform technology for oral delivery, either as buccal, sublingual or via dissolving on the tongue, and as a transdermal patch or gel. Its products include cannabinoids.
Datwyler supplies sealing, closure and packaging to the automotive, healthcare and consumer goods industries. Its healthcare division offers advanced elastomer formulations, coatings, aluminium seals, and processing technologies for drug packaging and medical devices.
DCA is a product design consultancy offering engineering, design, HF, electronics/software, prototyping and other services to multiple industry sectors. It has extensive experience (50+ full-scale projects) in drug delivery, including injectors, inhalers, wearables, and electronic/connected devices.
Debiotech develops medical devices, including drug delivery systems, artificial organs and diagnostics. Within drug delivery, and including connected/smart devices, its portfolio comprises handheld and on-body SC injectors, IV injectors, and intradermal microneedles.
DelSiTech provides the technology and expertise for solving drug delivery problems. The company's technology is based on amorphous silica (SiO2) matrix and sol-gel encapsulation technique. DelSiTech also develops its own pipeline of in-house and partnered supergeneric drug products.
DFE Pharma's broad excipient portfolio includes starch, lactose and microcrystaline cellulose, with applications as, for example, inhalants and superdisintegrants. The company both manufactures excipients and partners with pharma companies to improve their product performance.
DIANT Pharma develops proprietary continuous manufacturing technology, including its scalable jet technology, for nanoparticles with a wide array of applications throughout multiple industries, such as lipid nanoparticles (LNPs) and liposomes for pharmaceutical formulations.
Dolomite Microfluidics is the microfluidics division of Blacktrace Group, which designs, develops and manufactures technologies and products with applications in chemistry, microfluidics, biology, nanomaterial sciences. It turns scientific discoveries into cutting-edge commercial products.
Double Bond Pharmaceutical uses its proprietary drug delivery technology, BeloGal for the development of treatments for cancer, infectious diseases and other therapeutic indications. BeloGal formulations target diseased organs and are delivered intravenously or subcutaneously.
Dow Pharma Solutions was a business of the DowDuPont Specialty Products Division that developed functional excipients, APIs and medical-grade adhesives. In late 2018 / early 2019 it was fully integrated into DuPont to become the Pharmaceuticals division of DuPont Nutrition & Health.
This company is inactive
Dr Reddy's Custom Pharma Services (CPS) draws on Dr Reddy's expertise in pharmaceutical development and manufacturing to provide customised services and solutions. Amongst the wide range of services Dr Reddy's CPS offers is innovative dosage form development and manufacture.
DTF Medical specialises in the design, manufacture and sale of medical devices in the areas of aerosol therapy, breast feeding and wound care. Its aerosol therapy division offers a line of devices, including nebulisers, for broncho-pulmonary, ENT, sinus and otolaryngology pathologies.
Duoject designs and develops advanced custom medical devices for the pharmaceutical industry. It also supports client development programmes including through regulatory affairs, manufacturing and project management. Every project creates a strong IP background.
E3D's autoinjectors and patch pumps are for conventional drugs, biologics and biosimilars. It offers autoinjectors that are compatible with drugs in vials, prefilled syringes and cartridges, and also disposable and reusable autoinjectors. E3D emphasises customisability and flexibility.
EdgeOne Medical provides integrated project management, product verification & validation testing, quality, and regulatory services in medical device and combination product development to device manufacturers including to >10 of the top 50 medical device and biopharma companies.
Eitan Medical develops drug delivery systems, including wearable injectors and infusion solutions, that put patients at the centre of care, making drug delivery easier and safer. The devices are applied across the continuum of care, including hospital, ambulatory and home-care environments.
Elektrofi is a biotechnology company developing technologies, including Elektroject™, that enable protein therapeutics to be conveniently administered to patients in small-volume syringe injections instead of large-volume IV infusions or frequent injections.
Emergo by UL is a regulatory consultancy specialising in medical device, combination product and IVD compliance. Its human factors research & design (HFR&D) global team specialises in early-stage user research, product design, usability testing and user interface design.
EmulTech develops microspheres which can be used for controlled and sustained release, the delivery of poorly soluble APIs, to provide taste masking, to enable targeted delivery; and to improve stability. The company's process enables tight control over particle size and other characteristics.
Enable Injections is developing the enFuse™ discreet, convenient, body-worn injection device. It is compatible with any standard container closure system, including a syringe or vial and allows self-administration of high-volume (up to 50 mL) and/or high-viscosity therapeutics.
Encompass Ophthalmic Development, part of Encompass Pharmaceutical Services, offers services including preclinical support, drug development, reformulation, to improved product characteristics. Drug delivery system development is included in its service offering.
Envigo provides products and non-clinical research services for pharmaceutical, crop protection and chemical companies, universities and governments. Its pharmaceutical services include product development and medical device testing, amongst numerous others.
Envisia Therapeutics was developing the PRINT® technology, a proprietary system capable of creating precisely engineered, sustained release products via a fully-scalable manufacturing processes. In October 2017, Envisia's technology and other IP was acquired by Aerie Pharmaceuticals.
This company is inactive
EPIWatch is a start-up company based in the Netherlands dedicated to creating viable solutions for patients who need immediate access to self-injected emergency medications. The EPIWatch is a wearable autoinjector, worn like a watch.
Equashield provides manual and automated solutions for compounding and administering hazardous drugs. Its products include EQUASHIELD CSTD, its flagship closed system transfer device (CSTD), and EQUASHIELD Pro, the first ever closed system-enabled automated pharmacy compounding system (APSC).
EVEON is an ISO13485-certified company that designs and produces automatic, secure and connected medical devices for the preparation and delivery of therapeutics. Its expertise has been recognised by Forbes, which ranks EVEON as the third most inventive company in France in the medical technologies category.
Evonik Health Care is a CDMO for advanced oral and parenteral drug delivery solutions covering early development to commercial manufacturing. Evonik Health Care is also one of the world’s largest CMOs for APIs, intermediates, amino acids, cell culture ingredients and medical device excipients.
Exopharm uses extracellular vesicles (EVs) for the delivery of various types of active ingredient, including DNA, RNA, small molecules and proteins, to selected cell types and organs. Exopharm’s manufacturing technology, Exopharm uses its technologies in its own product pipeline as well for biopharma partner drug candidates.
Experic is a CDMO and pharma supply services company covering every phase of the product lifecycle from clinical to commercial scale, across a range of dosing and packaging formats, including capsule filling, powder and pellet dosing (including DPI), and autoinjectors and pen assemblies.
EYE-GO is a medtech start-up developing MistGo® a new-generation proprietary microdosing drug delivery system (compatible with preservative-free drugs) that mitigates the imperfections with current eye-drop bottles.
EyePoint Pharmaceuticals is a specialty biopharmaceutical company committed to developing and commercialising ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders. Eyepoint was formerly pSivida.
Eyevensys is using its EyeCET gene therapy electroporation technology, which enables the sustained intraocular production of a range of therapeutic proteins, to develop a pipeline of products that overcome the limitations of existing invasive treatments and address unfulfilled therapeutic needs.
FabRx is developing better medicines using patented 3D printing technology to enable medical treatments to be personalised to the individual needs of each patient (in terms of dosage, shape, size and dose combinations) for production on site in pharmacies or clinical trials units.
Freeman Technology, a Micromeritics company, specialises in systems for measuring the flow properties of powders and has >15 years’ experience in powder characterisation. It invests significantly in R&D and applications development, and provides full support alongside its range of products.
Flex is a global design development and manufacturing organisation that partners with medical and pharma companies, to bring technologies in connectivity, sensors, miniaturisation and others, to new product design and manufacturing, to deliver medical quality at large scale.
The Fluids and Structures (FaST) Lab in the Mechanical and Aerospace Engineering Department at the University of Central Florida investigates the physics governing flow at the interface of fluids and deformable solids. The lab’s research is inspired by natural systems.
ForSight VISION5 was acquired by Allergan in 2016. It was focused on developing non-invasive, sustained drug delivery products to replace eye drops, for eye diseases including glaucoma and dry-eye. The acquisition included US$95 million upfront and a launch milestone on its lead programme.
This company is inactive
Gattefossé is a provider of speciality ingredients and formulation solutions for the beauty and healthcare industries. The company's particular expertise is in lipid chemistry and excipients, and it provides a range of products for use in formulations for the oral, topical, parenteral and vaginal/rectal routes.
GEKA Healthcare has adapted technology used in cosmetics to develop drug applicators with delicate microbristles for precise, hygienic application. Its patented systems are based on injection moulding technology, and have applications in topical / dermal and buccal delivery.
The Georgia Institute of Technology, also known as Georgia Tech, is a public college and research university in the United States. The graduate PhD and MS Bioengineering programme at Georgia Tech lists Pharmaceuticals and Drug Delivery as one of its research areas of interest.
Gerresheimer is a major drug delivery device and primary packaging company. Its products include insulin pens, inhalers, prefillable syringes, pharma plastic containers, and glass ampoules, vials, and cartridges. Gerresheimer Bünde is its centre of excellence for glass prefillable syringes and cartridges.
GCAC is a leader in designing and developing innovative software-as-a service (SaaS) data technologies specifically for the medical cannabis industry. The company’s technologies benefit the ecosystem by helping the cultivator control and optimise the product lifecycle.
Glycome BioPharma is applying its glycoscience technology to serve the global pharma and biopharma industry. The company has significant development capabilities in the field of organic chemistry for the development of novel methodologies, functional materials and their optimisation.
Granutools combines decades of experience in scientific instrumentation with fundamental research on powder characterisation to develop and manufactures instruments that measure physical powder characteristics such as: flow, static cohesion, dynamic cohesion, tapped density and tribo-electric charge.
Graybug Vision is developing products to reduce the frequency of dosing for ocular therapies using its injectable and implantable controlled-release technologies, which address low compliance to self-administered eye drops by allowing the physician to manage treatment.
/H&B/ Electronic offers high-precision mechanical components, connectors, sensors, housings and electromechanical systems. It has developed patented solutions for single-use, reusable and electromechanical injectable drug delivery devices, including its Four-Step-Technology.
H&T Presspart components are used in 85% of the world’s MDIs. Its products include MDI counters, actuators and canisters; the PowdAir Plus DPI; and the connected eMDI. Manufacturing services including medical devices and injection moulded and deep-drawn metal drug delivery components.
HCmed Innovations is developing portable, vibrating-mesh neubilisers, including Pulmogine, able to nebulise solutions, suspensions, biologics, and high viscosity drugs. Its devices have received regulatory approvals in various territories including Europe, Taiwan, Brazil and Indonesia.
Harro Höfliger develops and manufactures production and packaging equipment. It offers numerous machines including for assembly, cartoning, dosing and filling, foil forming, handling and inspection. Applications include in assembly of inhalers and injectors, sterling filling, packaging and assembly.
Harvey Medical provides consulting services in human factors and market research for medical devices and combination products. It has an in-house multidisciplinary team of human factors and market research specialists, covering the entire product development cycle.
Haselmeier, the drug delivery device business division of medmix, designs, develops and manufactures user-friendly injection systems that enable patients to self-administer their medication reliably and accurately based on its proprietary IP and a broad portfolio of technologies and services.
Health Tech Enterprise (formerly Health Enterprise East), a technology advisory and innovation management company with links with the UK NHS, other government organisations, and industry, provides medtech consulting, investigates health economics, facilitates connections and manages IP.
HEKUMA offers high-performance, automated injection molding processes to the medical, consumer goods, automotive and technology industries. Within the medical field it provides processes for the production of inhalers, auto injectors and prefilled syringes.
Hosokawa Micron specialises in powder and bulk processing for numerous industries. Among its pharma offering it provides solutions for turning raw materials and excipients into finished dosage forms, including respiratory drugs, dry powders, tablets, and solid crystals.
Hovione has an extensive CDMO offering, off-patent API capabilities, a proprietary product pipeline and associated supporting services and capabilities. Inhalation is a notable area of focus for Hovione. It has developed its own DPIs, and offers inhalation product development services.
Hovione Technology was created when Hovione spun out its inhalation devices. Its portfolio includes a two-component, low-cost DPI called TwinCaps when used for low-to-medium doses and TwinMax for high doses; and PowdAir, a four-component, capsule-based, re-usable, low cost inhaler.
Founded in 1978, HS Design is a medical and lifescience focused, user driven product design and development company, comprising researchers, human factors engineers, designers, engineers, marketing and manufacturing experts. The company has designed >400 successful products to date.
Iconovo develops novel inhaled products in collaboration with international pharma companies, providing several types of patent-protected inhalers, with significant commercial opportunities in the development of novel products and in patent expirations for established pharmaceuticals.
IFF offers a vast portfolio of differentiated ingredient solutions for customers of all sizes, across […]
IGS GeboJagema is a high-precision mould solution company that collaborates with OEMs early in the lifecycle, on the design, manufacture, validation and maintenance of moulds for products where extreme precision is vital, including asthma inhalers, insulin pens and diagnostic devices.
IMA Group designs and manufactures processing and packaging machines for multiple industries, including pharmaceuticals. Its Pharma business has three divisions: IMA Active (solid dose), IMA Life (aseptic processing & filling), and IMA Safe (blisters, capsules, tablet counters and tube fillers).
Inhalation Sciences develops and sells patented labtech equipment for inhalation research that give labs, pharma and research companies exceptional quality data in their PK studies, including the aerosol R&D system, PreciseInhale, which generates high-quality aerosols and data
Injecto develops, produces and markets primary pharmaceutical packaging, with a focus on injection safety and protection of parenteral formulations. Its lubrigone plunger stoppers enable an entirely lubrication-free injection system without ETFE/PTFE coatings or silicone.
Innovation Zed is developing connected health solutions including the Enya system, a connected, customisable, compliance platform add-on for injection pens. It comprises a range of connected devices with incremental functionality that auto-collects usage data.
Insight Product Development was acquired by Nemera in August 2019 and fully integrated as the Nemera Insight Innovation Center, which provides innovation design consultancy in the medical devices, drug delivery and consumer health fields with a user-centred design approach.
This company is inactive
Insmed is a global biopharma company developing treatments for patients with serious and rare diseases. Its first commercial product, ARIKAYCE® uses the company's pulmonary liposomal drug delivery system, PULMOVANCE, which delivers the API directly to the site of lung infection..
Inspired Usability combines knowledge of product development and human factors regulations to inform the design process. It has experience with a range of drug delivery devices, hospital-based medical devices, surgical equipment, smart devices, apps, wearables and consumer health products.
Integral BioSystems is a contract research organisation specialising in drug delivery R&D, drug development and intellectual property, in particular the design and development of dosage forms for ophthalmic, transdermal, intravenous, intranasal and oral routes of drug administration.
Intertek Melbourn provides analytical and formulation services to pharma, biotech and drug delivery, with expertise in inhalation and other dosage forms. Services include performance testing, method development/validation, stability, CMC, formulation development and clinical manufacturing.
Intract Pharma's portfolio of oral delivery systems includes controlled-release technologies targeting specific regions of the large and small intestine, and a technology for enabling oral delivery of biotherapeutics previously only suitable for injection. It has also developed proprietary GI models.
Ipsen is a global, speciality driven pharma company with interests in oncology, neuroscience and rare diseases. Its drug delivery systems expertise includes systems for intracellular delivery of peptides and sustained release / long acting peptide formulations.
The International Society for Aerosols in Medicine (ISAM) is a scientific society focused on all areas of aerosols including health effects of aerosols and pulmonary drug delivery. ISAM was founded in 1970 with an objective to foster interdisciplinary communication within the areas of aerosols in medicine.
Jabil Healthcare is the medical device, diagnostics, pharmaceutical and consumer health arm of Jabil, a US-based global product and manufacturing services company. Jabil Healthcare provides services through design and development, engineering to manufacturing for drug delivery devices.
Kahle Automation designs, builds and implements automation systems for medical, pharmaceutical and healthcare device companies, including drug delivery device companies. Applications include needle assembly, syringe assembly, tubing assembly, glass syringe assembly, safety device assembly.
Kala Pharmaceuticals develops a pipeline of ocular products using its MPP technology which enhances penetration through the tear film mucus. Beyond ophthalmology, it has potential applications include women’s reproductive health, respiratory and gastrointestinal diseases.
Kaléo is a pharmaceutical company whose products combine established drugs with innovative delivery platforms, including aerio, its autoinjector platform for emergency administration. Its pipeline includes products for allergic reactions and opioid overdose, among other indications.
Kallik is a global provider of labelling and artwork management solutions for regulated markets such as the pharmaceutical, medical devices, cosmetics and chemicals industries. Kallik was established in 2001 based on its flagship labelling content management and automated artwork generation platform.
Kedalion Therapeutics, acquired by Novartis in 2022, was a clinical-stage ophthalmic drug delivery company developing the AcuStream technology. The device's horizontal stream delivers topical ocular drugs precisely and accurately, aiming to reduce required dose compared with standard drops.
This company is inactive
Kerry Group's pharma offering has its roots in dairy and lactose production. Its products include pharmaceutical-grade lactose excipients, film coatings, self-lubricating excipients, tableting systems and flavours, with applications in oral solid dosage forms, syrups, oral capsules and dry powder inhalers.
Kestrel Technology Consulting works with its clients and partners on innovative technology and product development projects in numerous industrial sectors including medical (drug delivery, surgical, home healthcare, ophthalmic, biotechnology) and sustainable design and manufacture.
Key Tech designs and develops medical, industrial and consumer products using novel sensors, wireless, ultrasound, microfluidics, optics and robotics. Its experience within drug delivery includes with injection devices and connectivity. It has an interdisciplinary team of scientists, engineers and designers.
Kindeva Drug Delivery, formerly 3M's drug delivery business, is a CDMO offering integrated, end-to-end formulation, product development, scale-up manufacturing and commercial manufacturing services, with an innovation offering spanning inhalation, transdermal delivery, and microneedles.
King's College London is one of the top 25 universities in the world. Its Drug Delivery Research Group undertakes R&D in pharmaceutical technology and applies scientific principles both in the formulation of medicines and in the development and use of predictive models of drug absorption.
Körber Pharma, the pharma business of Körber Group, offers a broad range of pharma packaging solutions, including: packaging and transport; inspection; consulting and software; and tracking. It is a major supplier of secondary packaging solutions, specialising in packaging for parenteral products.
KORU Medical is a medical device company that designs, develops, manufactures and supports subcutaneous infusion systems, specialising in ultra-large volume drug delivery. Its main products comprise the Freedom Integrated Infusion System.
Kymanox is a life sciences consultancy that offers engineering, scientific and compliance support to companies exclusively in the biotechnology, pharmaceutical, medical device and combination product industries throughout the product lifecycle from early development to postmarket.
Latch Medical is developing a platform microneedle technology, centred around opposing arrays of angled microneedles that can penetrate the outer layers of the skin for consistent needle penetration without adhesive. Pharma Latch is the drug delivery device based on the platform.
leon’s proprietary technology platforms offer access to the next generation of SMART nanoparticles and nanoformulated drugs, adding value across the supply chain, from partners and payors to caregivers and patients, revitalising forgotten formulations, and breathing new life into generics.
Lexaria Bioscience develops innovative drug delivery platforms including the patented DehydraTECH™ for the delivery of lipophilic molecules. DehydraTECH™ increases bio-absorption, reduces time of onset, and can reduce drug costs for orally administered bioactives.
LiberaTx is using its proprietary extended-release technology to reformulate existing marketed pharmaceuticals to improve treatment outcomes, while reducing the pill burden on patients, with an initial focus on alleviating levodopa-induced dyskinesia in Parkinson’s disease.
LMGP, a joint research unit of the Grenoble Institute of Technology and CNRS, develops materials with scientific applications and applications in biomedical engineering including functional thin films, surface nano-engineering and interactions between materials and biological matter.
Logan Instruments is a provider of laboratory instrumentation to the global pharmaceutical and cosmetics industries, with a focus on physical, dissolution and transdermal testing systems. Constant R&D means its tried a trusted line of established instruments is always being augmented.
Lonza is a large, Switzerland-based multinational CDMO serving and supplying products to partners in the global pharma, biotech and nutrition markets. The company has four segments: Small Molecules; Biologics; Cell & Gene; and Capsules & Health Ingredients.
Lovelace Biomedical is a large, not-for-profit CRO with interests including respiratory, infectious diseases, gene therapy, neuroscience, alternative tobacco products and medical countermeasures. Respiratory expertise includes formulations for DPIs, MDIs and nebulisers.
LSS offers individually designed and customised labelling solutions that meet the unique requirements of the pharma industry, ranging from simple offline systems and automatic label dispensers to integrated labelling systems, including for vials, ampoules, syringes, autoinjectors, pens and boxes.
LTS is a pharmaceutical technology company that develops and manufactures drug delivery systems for pharma partners, with a focus on transdermal therapeutic systems (TTS), oral thin films (OTFs) and micro-array patches (MAPs). Its systems are applied in more than 20 marketed products.
Lucideon is a development and commercialisation company focusing on materials technologies and processes for mutliple industries. It has an extensive pharma offering including formulation development, E&L, powder processing, and its own controlled release drug delivery technology, iCRT.
Lux Research provides market intelligence, focusing on technology-driven innovation. Its areas of focus include materials, health, food & wellness, digital and energy. The materials and health areas include coverage of drug delivery related aspects.
The health business team at Lubrizol Life Science partners with customers to speed their innovative medical devices and pharma products to market. Its team provides high-quality polymers and excipients, along with state-of-the-art product design, development and manufacturing services.
Macquarie University Medical School’s Faculty of Medicine, Health and Human Sciences conducts research spanning the […]
Malvern Panalytical's scientific measurement instruments are used by the pharmaceutical industry to confirm the identity, activity, molecular conformation, morphological properties, solid form and stability of APIs and excipients. There are many applications in drug delivery.
MannKind Corporation focuses on the development and commercialisation of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. MannKind is currently commercialising its US FDA-approved Afrezza® (insulin human) Inhalation Powder.
Marchesini Group is a manufacturer of automatic pharmaceutical and cosmetic packaging machines, based in Italy's Packaging Valley. The company's pharmaceutical solutions cover aseptic, liquid, inspection, solid, powder, cream, labelling and serialisation, secondary packaging, and end of line.
Matchstick is speciality consultancy focused on pre-concept and concept stage development of combination products including medical devices, patient support and engagement programmes, training and lifecycle strategies. The company has a strong focus on drug delivery devices.
Mati Therapeutics is developing its Punctal Plug Delivery System, a minimally invasive technology that can be used to introduce a variety of therapeutic agents to the eye through controlled, sustained release to the tear film. Initial target indications are glaucoma and ocular hypertension.
maxon motor provides high-precision motors across a range of industries. Its motors can be used to drive various drug delivery systems, including insulin pumps. The company is working on the next generation of drive solutions for drug delivery, including for syringes and needle-free solutions.
MC10 developed wearable products using ultra-thin, flexible body-worn sensors with advanced analytics to gain health insights from physiological data, giving potential in data monitoring and gathering with connected delivery systems. It was acquired by Medidata in 2020.
This company is inactive
Medical Device Usability (MDU), a consultancy specialising in usability and human factors for medical devices, performed formative and summative human factors studies for global pharma, medical device and diagnostics clients. MDU was acquired by UL in 2018.
This company is inactive
Medical Engineering Technologies specialises in medical device and packaging testing, including drug delivery devices such as autoinjectors. MET is equipped for performance testing, chemical analyses and sterile barrier verification, and with accreditation to ISO 17025.
Medicom Innovation Partner was acquired by Phillips-Medisize in 2016, and fully integrated. It developed connectivity services including for injectable, inhalable and oral drugs and provided development and pilot/low-volume production services focused on rare diseases and orphan drugs.
This company is inactive
Medicsen is developing SmartPatch, a transdermal delivery system that uses sonophoresis (based on patented, miniaturised ultrasound-generation technology) to create a transitory disorganisation of the stratum corneum, increasing the skin's permeability, including to macromolecules.
MedPharm operates a hybrid business model, with a CRO business focusing on pharmaceutical development and a patent portfolio of topical and transdermal delivery systems. Its expertise is in topical (skin, nail, eye, nose, lungs and other mucosal membranes) and transdermal products.
Medspray develops spray nozzles for user-friendly consumer health (nasal, ophthalmic, topical), pharma and personal care products, making propellants redundant and increasing user friendliness. Its nozzles can be used for various purposes, especially where a slow-moving, soft spray is required.
Merck Group is a global science and technology company. In the healthcare sector, the company has a broad range of interests, including specialty pharma and biopharma research and development, and a major software design centre for connected drug delivery devices.
Merxin designs and supplies generic and customised inhaler device platforms, including multidose dry powder inhalers, capsule dry powder inhalers, soft mist inhalers, no heat no PG vaping devices and devices tailored to cannabinoid delivery to the lungs and nasal cavities.
Metric Contract Services, founded in 1994, now a division of Mayne Pharma, is an oral solid dosage form CDMO providing formulation development, analytical testing and commercial manufacturing services to support drug development from concept to global commercialisation.
Mexichem Fluor, a division of the multinational chemical company, Mexichem, is one of the largest developers, manufacturers and suppliers of fluorochemicals in the world. Its hydrofluoroalkanes (HFAs) are used as propellants in 80% of all metered-dose inhalers.
Micro Engineering Solutions is a micro device product development and design service provider to medical and drug delivery device OEMs. The company offers vertically integrated micro fabrication, clinical knowledge, and scalable design and risk mitigation plans from product concept to high-volume.
MG2 supplies automatic machines for the pharmaceutical, cosmetic and food industries, including containment solutions, capsule fillers for oral dosage forms and inhalation applications, and primary and secondary packaging solutions, all supported by a full service offering.
Microdermics is developing and commercialising a novel hollow microneedle platform, which has applications both in bio-sensing and intradermal drug delivery. The technology is intended to provide minimally invasive precise and easy access to the skin.
MicroMED is a MEMS microchip design house specialising in the development of microinjection devices targeting unmet needs in the most challenging drug delivery applications. It has established a proprietary high-precision MEMS drug delivery engine system.
Micromeritics supplies characterisation systems for particles, powders and porous materials. Focusing on physical properties, chemical activity and flow properties, its portfolio includes pycnometry, adsorption, dynamic chemisorption, intrusion porosimetry, powder rheology, and particle size.
Micron Biomedical is developing a proprietary applicator-free dissolving microneedle patch technology to enable products with enhanced therapeutic efficacy (including vaccines with enhanced immunogenicity), simplified logistics and improved patient compliance.
Midas Pharma is a mid-sized pharmaceutical company that offers products and services across the full industry value chain, using a virtual model that provides expertise and project management around pharmaceutical supply chains, while connecting partner companies.
Midatech Pharma develops and commercialises products in oncology and other therapeutic areas, based on its two platform technologies - a drug-conjugate targeting technology and a micro-encapsulation technology for prolonged release - that can be used alone or in combination.
Mikron Automation provides scalable and customised assembly systems across numerous industry sectors. Within medtech and pharma, it serves both the parenteral and inhalation delivery device categories, from proof of principle through clinical pilot lines to fully automated solutions.
MGC is a major chemical products manufacturer operating across a wide range of industries. In the field of drug delivery, the company's Advanced Business Development Division has developed OXYCAPT™ Vial & Syringe from a novel polymer, as an alternative to glass primary packaging.
Monash University is a major global, research-intensive university. Research (including partnerships with industry) on drug delivery-related topics are conducted in the Department of Mechanical and Aerospace Engineering as well as at Faculty of Pharmaceutical Sciences.
N4 Pharma is developing Nuvec, a silica nanoparticle vaccine and cancer therapeutic delivery system. It partners with companies developing antigens to use Nuvec as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity.
Nanoform is a nanoparticle medicine enabling company that works with pharma partners to reduce attrition in clinical trials and enhance formulation performance of molecules through its nanoforming™ services. Its CESS® technology produces nanoformed™ API particles as small as 10 nm.
Nanopharm, an Aptar company, provides integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics for tailored analytical and drug development, with a focus on orally inhaled and nasal drug products.
The National Physical Laboratory (NPL) is the UK's National Metrology Institute, which develops and maintains the national primary measurement standards that allow technological advances to be built on a foundation of reliable measurement. The organisation is more than 100 years old. For over a century, we have worked with customers to translate scientific expertise into economic prosperity, skilled employment and improved quality of life.
Natoli Engineering Company specialises in tablet-press tooling manufacturing, also providing presses and replacement parts. The company is a major industrial supplier and has more than 40 years experience. Its Scientific and Metallurgy divisions provide testing and analysis services.
Nebu~Flow is a start-up medical device company developing the Nebu~Flow technology in the form of a user-friendly nebuliser for efficient inhalation delivery of a wide range of formulation types. Nebu~Flow can be tailored, enabling development of multiple drug-nebuliser products.
Nelipak Healthcare provides custom designed thermoformed packaging for the medical device and pharmaceutical industries. Its drug delivery-related offering includes robotic handling tray solutions for applications such as dry-powder inhalers, autoinjectors and prefilled syringes.
Nemaura focuses on drug delivery through the skin and, in addition to its Micro-Patch microneedle solid dose delivery system, has programmes involving topical gels, transdermal patches, simple injectable drugs for SC, IM and ID delivery using liquid micro-injectors, and complex injectables.
Nemera designs, develops and manufactures parenteral (passive safety devices autoinjectors, pens, and implanters), nasal, buccal, auricular, ophthalmic, pulmonary, dermal and transdermal drug delivery devices for the pharmaceutical, biotechnology and generics industries.
Hoffmann Neopac supplies metal and plastic packaging, including droppers for drug delivery, with an emphasis on sustainability and ecological design. Its Polyfoil® range includes single-dose tubes and airless pump or dropper tubes, and those with tamper-proof and child resistant features.
Neuma is an engineering services company focused on development of robust, verifiable, reliable and manufacturable drug delivery devices. Experience includes work on novel, custom, and platform adaptations across prefillable syringes, autoinjectors, reconstitution devices and wearable injectors.
Neurelis is a privately held specialty pharmaceutical company focused on licensing, developing and commercialising product candidates for epilepsy and the broader central nervous system market. Its lead and other pipeline products are mainly delivered via the nasal route.
In the area of drug delivery, New Directions Technology Consulting is the exclusive market developer for the mMed patent portfolio. Medication telemanagement systems based on the portfolio can be used to develop innovative health and wellness programmes.
Nexeon MedSystems is a bioelectronics company developing active medical devices. It has a diversified portfolio of products for treating patients with chronic medical conditions including cardiovascular disease. Its team has track records of successfully developing and commercialising new technologies.
Next Breath is a full-service cGMP-compliant laboratory specialising in analytical testing of a range of drug delivery systems, providing solutions from formulation and CMC support, to finished batch release and post-approval stability, to regulatory agencies worldwide.
Noble, an Aptar Pharma company, supplies onboarding and training devices, such as mechanical and smart, error correcting autoinjectors, prefilled syringes, on-body injectors, inhalers, angle aid tools, auditory packaging and other multisensory solutions, to pharma and biotech clients.
Nordic Group is a privately owned pan-European pharmaceutical company that focuses on the development and commercialisation of niche hospital and orphan products for to unmet medical needs. Nordic both develops products in-house and works with partner products acquired during development.
Nordic Semiconductor is a semiconductor company specialising in ultra-low power and low power wireless communication and is a member of the Bluetooth Special Interest Group. There are numerous applications of its wireless communication products in the field of connected drug delivery.
No Type is a patient-centric medical behaviour technology company developing the No Type app. It was founded by a team with experience across medical devices, usability research and technology with an aim to help improve patient voice and improve medical devices and pharmaceuticals.
Novaliq is a German ophthaltmic pharmaceutical company. The company's products are centred on its proprietary water-free technology, EyeSol® for topical ocular drug delivery. Novaliq is focused on developing the technology for use in treatments for dry eye disease.
NovInject is a spin out company from the Université Libre de Bruxelles Bio-, Electro-, and Mechanical Systems (BEAMS) department, commercialising an innovative approach to injection by the intradermal route, where administrating through the skin means bypassing the skin protective layers.
NXP Semiconductors is a major provider of secure connectivity solutions for embedded applications operating in the automotive, industrial & IoT, mobile and communication infrastructure markets. The company was founded in the 1960s, has approximately 31,000 employees in >30 countries.
Oculinea (formerly Zordera), a spin-out company from the University of California, San Francisco, US, is developing proprietary nano-engineered polymer film technology, which has been developed for the long-term delivery of small and large molecule ocular therapeutics.
Established in 2004, and trusted for its high quality contributions from leading experts, ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with pertinent industry information and intelligence about drug delivery-related ideas, technologies, services and products.
Ora is a full-service ophthalmic drug and device development firm which, over 40 years, has helped clients earn more than 55 product approvals. Its preclinical and clinical models, methodologies and global regulatory strategies have been refined and proven across thousands of global projects.
Orbis Biosciences was acquired by Adare Pharmaceuticals in May 2020 and its particle design technology and controlled release delivery systems for oral and injectable products are being integrated into Adare's technology offering. Visit the Adare's profile for latest content and information.
This company is inactive
Otitopic, acquired by tobacco company Philip Morris International in 2021, was a dry powder inhalation company with expertise in formulation and drug delivery device development, including Asprihale®, a proprietary DPI aspirin formulation for cardiac indications.
This company is inactive
Oval Medical Technologies is a drug delivery device design and development company, specialising in patient-centric autoinjectors. The company develops devices to handle a wide range of formulation requirements, with designs that include proprietary custom primary containers.
Owen Mumford is a medical device manufacturer that develops products for its own brand and custom device solutions for pharmaceutical and diagnostic companies. Owen Mumford provides research, design and manufacturing capabilities for device production.
PA Consulting is a multinational consulting company covering a broad range of industries. In healthcare, PA works with both private and governmental clients on a variety of projects, particularly in the fields of of advanced digital technology and healthcare management.
Panarum Corporation is developing its Proteoral® technology for the delivery of therapeutic polypeptides, which works by innocuously opening intercellular junctions of the intestinal epithelium. The company is privately owned. It was founded in 2017 with investments from angel investors.
Economy Spring, a division of MW Industries, is a manufacturer of metal medical device components, including highly-engineered, precision metal components and assemblies such as springs, surgical sharps, needles, laser machined tubing, staples, titanium clips and complex assemblies.
PARI provides devices and solutions for inhalation for pulmonary, bronchial and also nasopharyngeal diseases. A broad product portfolio offers comprehensive patient care, ranging from diagnosis and treatment to monitoring. PARI works with advanced aerosol delivery platforms.
PCI Pharma Services is a pharmaceutical partnering company that provides outsourced services across the drug development lifecycle. The company's offering covers manufacturing services, clinical services and commercial packaging, including drug delivery devices
The Parenteral Drug Association is a global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA provides information and resources with the expertise of its nearly 10,000 members worldwide.
Philips Capsule (formerly Capsule Technologies until its acquisition by Philips in 2021 and, before that, Qualcomm Life) is a healthcare information technology and services company that provided solutions for in-hospital and in-home medical device connectivity and data integration.
Phosphorex is a CDMO specialising in particle-based platforms such as LNP, polymeric microspheres and nanoparticles with applications in the nucleic acid delivery and sustained and targeted release. It offers solutions to optimise release rate, targeting ability, bioavailability and deliverability.
Picocyl's flagship products, Pico-Cylinders, are single use, pressurised gas cylinders with applications as the power source for numerous types of drug delivery system including: microinjectors, autoinjectors, implantables, nasal delivery, needle-free injection, wearable injectors and dermal injectors.
Pion provides pharmaceutical laboratory instrumentation and associated innovative technology, solutions, support and scientific expertise to the drug development industry. One of its offerings is the Scissor SubCutaneous Injection Site Simulator instrument.
Pfizer is a global pharmaceutical corporation headquartered in New York, with its research headquarters in Groton. It is among the world's largest pharma companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.
Pfizer CentreOne is a large global CDMO within Pfizer, and a leading supplier of specialty APIs. Its service offering is broad, spanning development and manufacturing services for sterile injectable and oral solid dosage forms. Its manufacturing network includes more than 35 sites across six continents.
PharmaJet is a medical technology company developing needle-free injectors for vaccine delivery. The PharmaJet Stratis® needle-free injector has US FDA 510(k) clearance, CE Mark and WHO PQS certification to deliver medications and vaccines intramuscularly or subcutaneously.
Phillips-Medisize provides innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, and medical device industries, specialising in integrating design, moulding, electronics, and automation, into manufacturing solutions.
Pierre Fabre Medicament is a division of Pierre Fabre Laboratories, a multinational pharmaceutical and cosmetics company. Pierre Fabre develops a wide variety of pharmaceutical products, primarily focused in the fields of oncology and dermatology.
PolyMicrospheres is a technology company offering research, development, and manufacturing of uniform polymer microspheres for clinical diagnostics, and microsphere- and nanoparticle-based drug delivery systems for the pharmaceutical, medical device and healthcare industries.
Portal Instruments is a clinical-stage medical device company, developing a needle-free drug injection platform for subcutaneous delivery of medication for patients suffering from chronic diseases such as ulcerative colitis, multiple sclerosis, rheumatoid arthritis and psoriasis.
Portescap offers a broad range of miniature specialty motor products, including coreless brush DC, brushless DC, stepper can stack, gearheads, digital linear actuators and disc magnet technologies, in a wide spectrum of industry applications including medical devices.
ProMed is a contract manufacturer of polymer-based drug releasing moulded dosage forms and combination device components. It combines state-of-the-art equipment and tooling to produce tightly toleranced parts for medical devices that are sold in the US, Europe and Asia.
Propeller Health is a digital therapeutics company that provides a connected health infrastructure for use with drug delivery devices designed to treat chronic respiratory diseases. The Propeller Platform is in use by patients, physichians and healthcare organisations in the US, Europe and Asia.
Proveris Scientific delivers innovative technologies, services, and deep product knowledge to a worldwide customer base of branded and generic pharmaceutical companies, device manufacturers, CDO/CRO/CMO’s, and regulatory agencies working with orally inhaled and nasal drug products.
Pulmatrix is a respiratory pharmaceutical company with a pipeline of novel and generic inhaled therapies. Pulmatrix is developing its products using its proprietary iSPERSE platform, a technology for development of dry powders without the need for lactose or other carriers.
PwC, one of the "big four" accounting firms. is a multinational professional services provider, is a network of firms in 158 countries with more than 236,000 people who are committed to delivering quality in assurance, advisory and tax services. Each of its member firms is a separate legal entity.
Qualicaps manufactures empty two-piece hard capsules for solid oral dosage forms and for use in dry powder inhalers, as well as a broad line of pharmaceutical processing equipment. The company's primary portfolio includes gelatin capsules, hypromellose capsules and DPI capsules.
Quantex specialises in single-use pump technology, including connected technology as the basis for an IoT platform. Its pumps have been adopted globally by blue-chip organisations in medical, pharma, food and beverage, consumer and industrial markets.
Queen's University Belfast is a member of the Russell Group of UK research intensive universities. One of the key research themes at QUB's School of Pharmacy is Drug Delivery and Biomaterials, and its research into micro-array patches for drug delivery has gained worldwide recognition.
QuiO was a connected therapeutics company that provided software and services enabled by smart medication devices. The company's ConnectedRx® cloud enabled pharma companies and healthcare organisations to measure real-world medication adherence and health outcomes.
This company is inactive
Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. Rani Therapeutics has developed a novel system, the "robotic pill", for oral delivery of large drug molecules including peptides, proteins and antibodies.
Raphas is a technology company focused on skin-based drug delivery techniques able to effectively permeate the skin barrier. The company is developing an innovative drug delivery system based on a microneedle patch that is effortless and painless to use for self-administration.
Raumedic is a polymer specialist that develops and produces customised components for the medical and pharmaceutical industries, including tubing, catheters and moulded parts as well as complex groups of components and systems for diagnostic and therapeutic uses.
Respiratory Drug Delivery, RDD®, hosts conferences in the US, Europe and Asia provide a venue for expert speakers to cover topics including: new therapeutic opportunities and drug delivery technologies, regulatory science and novel in vitro, in vivo and clinical testing methods.
Recipe Design is a strategic design consultancy specialising in the healthcare and home sectors. The company uses Meaning Centred Design, a unique process that helps clients understand how their customers and end users perceive their brand and proposition.
Recipharm is a pharmaceutical contract development and manufacturing organisation. Recipharm offers manufacturing services for pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development.
Research Center Pharmaceutical Engineering is an independent research centre. It develops physicochemical and predictive bases for addressing drug formulation and delivery challenges for oral, buccal, inhalation and implant products of small- and large-molecule therapeutics.
Resyca, a joint venture between Recipharm and Medspray, develops next-generation soft mist inhalers, including prefilled syringes inhalers, for the delivery of both small and large molecules, and designed to optimise lung deposition whilst minimising oropharyngeal deposition.
Respidex is a private consultancy helping pharma companies in their R&D activities, regulatory strategy, financing and commercialisation of products for prevention, diagnosis and treatment of diseases. Respidex clients include small early preclinical companies as well as those in late-stage clinical development.
Respironics Respiratory Drug Delivery (UK) is a healthcare technology company that designs and develops a broad range of drug delivery products for the respiratory and sleep markets. Respironics Respiratory Drug Deliveryis a subsidiary of Royal Philips of the Netherlands.
Re-Vana Therapeutics is an ocular pharmaceuticals and drug delivery company focused on the development and commercialisation of long-acting biodegradable drug delivery platforms to treat chronic eye diseases. It is a spin-out company from the School of Pharmacy, Queens University Belfast.
RISE Research Institutes of Sweden is a state owned innovation partner, working in life sciences and materials, with customers in industries including pharmaceuticals and medical devices. RISE comprises a network of research institutes and facilities across device development and technology.
The Rocky Mountain Poison & Drug Center conducts research in toxicity, progressive solutions in case management, emergency services and regulatory compliance. RMPCD is home to the RADARS® System, which collects specific data on abuse, misuse, and diversion of prescription drugs.
Röchling Medical manufactures customised components and assemblies, through to end-to-end OEM products, as well as standard plastic products. Its drug delivery systems offering encompasses a wide range of pharmaceutical applications (e.g. oral, nasal, parenteral, transdermal, ophthalmic, pulmonary).
Founded in 2020 from the merger between R&Q and Maetrics, but with roots going back to the 1980s, RQM+ is the largest medical device and diagnostics focused full-service regulatory and quality consulting firm in the world. It is privately owned, with offices in the US, the UK, and Switzerland.
Roquette is a family-owned company which produces a variety of products from starch extracted from plant-based raw materials. Roquette's products include speciality pharmaceutical excipients and food ingredients, tailored to the pharma, nutrition, food and selected industry markets.
RTP Company is a privately owned company that provides custom engineered thermoplastics to a variety of industries. In the healthcare sector, RTP Company works with medical grade resins for use in a wide variety of applications, including drug delivery devices.
SaferMed Technologies seeks partners to advance the development of its proprietary prefillable syringe, the SMPFS, whose novel glass-tube-plus-plastic-sheath design enables the use of a standard glass tube primary drug container, but avoids the need for the extreme thermal reforming process.
SABIC is a large Saudi Arabian petrochemicals manufacturer with a global presence and interests across industry sectors. Its healthcare offering includes the development and supply of polymer based materials and associated services, including for applications in medical devices and pharma packaging.
Sagentia Innovation is an end-to-end consultancy operating in the medical, consumer, food & beverage and industrial, chemicals & energy markets. Within drug delivery, it assists clients with innovative device design through to product development, including with integrating digital systems.
Samsung Biologics is one of the world's largest biotech-focused CDMOs, with more than 3,400 employees across sites in Republic of Korea and the US. Founded in 2011, it is the biotech division of Samsung Group. It has a track-record of successful regulatory approvals, large capacity and rapid throughput.
Sanner is a global German manufacturing company that develops and produces plastic packaging and drug delivery systems for pharmaceutical, medical and healthcare customers. Sanner specialises in desiccants and effervescent tablet packaging.
Santen Pharmaceutical is a global company in the business of research, development, production and marketing of pharmaceuticals and medical devices focused in ophthalmics. By focusing on ophthalmology, Santen develops unique scientific knowledge and organisational capabilities.
Scherdel Group's medtec division, Scherdel Medtec, provides metal wire and strip solutions, including springs, to the pharma, diagnostics and medical technology industries. Its pharma offering includes metal component solutions with applications in autoinjectors, pen injectors, inhalers and safety syringes.
SCHOTT Pharma is a provider of drug containment and delivery solutions for injectables, ranging from prefillable syringes, to cartridges, vials, and ampoules. It manufactures syriQ BioPure® glass prefillable syringes for biologics, and SCHOTT TOPPAC prefillable syringes, made of COP.
Scotia Vision is an ophthalmic consulting business specialising in drug delivery and medical devices for companies in the US and Europe. Scotia Vision has worked with a wide variety of ophthalmic companies and products, including multiple drug delivery technologies.
scPharmaceuticals is a biopharmaceutical company focused on the development of medications for subcutaneous delivery. The company's product pipeline is directed at developing at-home treatments for therapies traditionally administered intravenously.
Sensile Medical is a drug delivery technology company developing a wearable injector using its proprietary micro pump. Sensile's technology allows for programmable micro volumetric delivery of pharmaceutical and biopharmaceutical products, commercialised as a device platform.
Sensirion designs and manufactures digital microsensors and systems, in particular flow sensors. Sensirion sensors can commonly be found in the medical, industrial and automotive sectors, Its flow sensors are used in the creation of connected delivery systems such as inhalers.
SeriTech develops technologies and products that benefit from the natural properties found in silk, including a fast detaching, dissolving microneedle patch for the delivery of vaccines and pharmaceuticals. It has developed a scalable process to supply silk proteins to partners.
Sharp provides advanced clinical supply chain services and contract pharmaceutical packaging to the global pharma and biotech industry. Its solutions span Phase I clinical trials through to market, including for autoinjector and pen assembly, labelling and packaging.
SHL Medical designs, develops, and manufactures advanced drug delivery devices such as autoinjectors, pen injectors, inhalers and wearable drug delivery systems, and provides final assembly, labelling, and packaging services for leading pharmaceutical and biotech companies across the globe.
Shore Design Consultancy works in the medical, pharmaceutical, consumer, industrial and aerospace markets. In the field of drug delivery, Shore's expertise is in the field of usability, human factors and industrial design, which it uses in creation of drug delivery, diagnostic and training devices.
Silgan Dispensing supplies dispensing and closure systems for packaging in a variety of markets, including pharmaceuticals. The company provides highly engineered systems, such as droppers and sprays, for drug delivery via the ear, nasal, ophthalmic, oral and topical routes.
simatec is develops industrial innovations and technologies with broad applications. It is developing an electrically controlled, gas producing dry cell as an innovative power source for drug delivery devices such as autoinjectors and infusion systems.
Skyepharma is a CDMO that specialises in the manufacture of traditional and advanced solid dosage forms. It provides solutions bringing value to its clients at any stage of a product development lifecycle, from early- stage up to commercial manufacturing and packaging activities.
SMC Ltd. provides full contract manufacturing services for delivery devices from concept through to final packaged device including: programme management, design and development, product manufacturing, clinical manufacturing, electronics integration and global supply chain management.
Solvias is a CDMO providing integrated analytical services and solutions to the biopharma and medical device industries. Its OINDP testing portfolio supports the entire development cycle for a wide range of products, such as MDIs, DPIs, nebulisers, nasal sprays and soft mist inhalers.
Sonceboz designs, develops and produces mechatronic drive systems. In the medical/pharmaceutical sector, it provides motors for drug delivery systems such a wearable injectors, dual cartridge injection and automatic reconstitution, as well as developing a proprietary wearable injector platform.
sortimat provides assembly systems and feeder equipment and services to the medical, pharmaceutical and cosmetics industries and engineering companies, including semi-automatic assembly machines, and sophisticated end-to-end and fully-automatic assembly lines. It is owned by ATS Automation.
Specialty Coating Systems specialises in parylene conformal coating technologies and parylene engineering and applications expertise. The company provides coating services for applications within the medical device, electronics, automotive and military industries.
Spectradyne develops analytical technologies with a focus on delivering accurate measurements of particles in the submicron size range. The company operates across a broad set of industries, including pharmaceuticals and nanomedicine, cosmetics and semiconductor processing.
SPI Pharma is a pharmaceutical formulation technology provider, with a product range that includes antacid actives, excipients, taste-masking technology, drug delivery systems for tablets, fast-dissolve technologies, and other systems. SPI serves clients in over 55 countries.
Springboard is a privately owned technology and design consultancy. The company creates and develops new products and technology, including products in the field of medtech and drug delivery devices, assisting companies in resolving technical challenges and increase time to market.
Stabilitech Biopharma is applying its patented THERM-SB platform, for the thermo-stabilisation of viruses, vaccines, proteins and biopharmaceuticals, in the development of various technologies including the OraPro™ oral delivery system for biopharmaceuticals and vaccines.
SteadyMed Therapeutics was acquired by United Therapeutics in 2018. It focused on developing its PatchPump wearable injector platform, by developing its own therapeutic portfolio as well as working with partners to optimise the delivery of high volume, high value, small molecule or biologic therapeutics.
This company is inactive
Stevanato Group is a large, global provider of drug containment, drug delivery and diagnostic solutions to the pharma, biotech and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes and services across the entire drug lifecycle at each of the development, clinical and commercial stages.
Subcuject is a privately held technology company that functions as a virtual organisation, working closely with external experts and specialist organisations. The company develops an innovative and proprietary wearable device platform for bolus injection for delivery of biologics.
Sumitomo Rubber Industries has applied its know-how in the car tyre industry to the research and development of rubber medical products, including plungers and stoppers for parenteral primary packaging and delivery devices. Its facilities have achieved ISO9001 certification.
Tarsa Therapeutics developed TBRIA™, an oral formulation of calcitonin for postmenopausal osteoporosis. Rights to TBRIA have been acquired by R-Pharm JSC, whose US subsidiary is responsible for the continuing clinical development of TBRIA and subsequent regulatory submissions.
Technolution is a product development consultancy that works with pharma and medtech companies at all stages of development from initial concept through to the finalised product. Products it specialises in include medical devices, combination products and connected devices (IoT).
Team Consulting is a fee-for-service consultancy that works with pharma and medtech clients to design and develop medical devices, in particular drug delivery devices. In the field of drug delivery, Team Consulting's focus is in administation via the respiratory and parenteral routes.
teamtechnik specialises in highly automated assembly and testing systems in the fields of medical technology, new energy and e-mobility. Medical devices are a strong focus, in particular production systems for autoinjectors, injection pens, glass syringes and safety devices.
ten23 health develops, manufactures and tests products for the pharmaceutical industry and biotech start-ups. ten23 health supports its clients in developing differentiated, stable, usable and safe injectable treatment options for patients. swissfillon is a wholly owned subsidiary.
Terumo Pharmaceutical Solutions is a division of Terumo focused on designing and developing drug delivery devices. The company's product line includes pre-fillable syringe systems, hypodermic needles, catheters, infusion sets and safety devices for infusion sets and needles.
Tillotts Pharma is a gastroenterology-focused specialty pharmaceutical company, which markets its own products and offers technologies for intestinal targeted drug delivery: OPTICORE™ for colonic targeting, and ECX™, which targets the ileum and the ascending and transverse colon.
TISSIUM is developing and commercialising a synthetic polymer platform, based on a proprietary polymer family with properties including the ability to conform to, and integrate with, surrounding tissue. The technology has several applications in drug delivery.
Tjoapack is a contract packager of medicines, specialising in primary packaging for solid dosage forms, prefilled syringe assembly, labelling and packaging, vial labelling and packaging, kitting, and unit-dose packaging. The company operates in 42 countries across five continents.
Transdermal Specialties was a technology development company that designed delivery systems for the drug and cosmetic industries. The company had developed an ultrasonic transdermal delivery system, the U-Strip, with a focus on diabetes care via transdermal delivery of insulin.
This company is inactive
Trelleborg Group is a large supplier of engineered polymer solutions that seal, damp and protect critical applications in demanding environments. Its Healthcare & Medical division serves various areas, including applications in drug delivery systems and combination products.
TriboFilm Research is a technology development company specialising in medical device lubricants. With funding assistance from the US National Institutes of Health SBIR grants, TriboFilm has developed two alternative coatings to silicone oil: TriboGlide-DS® & TriboLink-Si®.
TruTag Technologies provides product identity verification solutions. TruTag offers a range of on-product (e.g on-dose) and on-package security solutions that provide manufacturers and government regulators with an effective means of securing their supply chains and safeguarding consumers.
TTP is an independent technology company that combines expertise in science and engineering. The company’s consultants are empowered to collaborate with clients, and each other, in a truly agile way. This has been a cornerstone of the company’s success for over 30 years.
The UCL School of Pharmacy is one of the most highly rated pharmacy schools in the UK. As the oldest School, founded by the Pharmaceutical Society of Great Britain in 1842 it has been dedicated to teaching and research in pharmacy and the pharmaceutical sciences more than 175 years.
Unilife Corporation developed, manufactured and supplied proprietary injectable drug delivery systems. Unilife's focus was on developing single-use safety syringes and wearable injector platforms for the delivery of biologics. The company ceased operations in 2017.
This company is inactive
The Institute of Applied Health Sciences is a research institute at the University of Aberdeen. The IAHS conducts population-based research into the need for, access to, evaluation of, and delivery of healthcare and collaborates with other universities, research institutes and agencies internationally.
Drug Tech (Drug Discovery and Delivery Technologies) is a Research Community within the University of Eastern Finland, investigating science and technologies that are relevant in drug discovery and delivery, facilitating the development of new drug candidates and delivery systems.
The University of Groningen is a public research university in the Netherlands. The Department of Pharmaceutical Technology and Biopharmacy performs research in the field of dosage forms, their production and their interaction with the living organism, including dry powder inhalation.
The Université Libre de Bruxelles is a french-speaking private research university in Belgium. ULB has interests in drug delivery in its Faculty of Pharmacy, as well as in its Faculty of Engineering's Bio-, Electro- And Mechanical Systems (BEAMS) department.
The University of Liège is a major public university in Belgium. The university's interest in drug delivery includes The Center for Interdisciplinary research on Medicines, which is a multidisciplinary research centre that teams up twelve laboratories from three different faculties.
The University of Parma is a state university in Italy. The University has interests in drug delivery in its Department of Food and Drug's research lines in pharmaceutical technology covering a range of delivery routes, including inhalation powders and transdermal delivery.
The University of Tours, formally University François Rabelais, has drug delivery interests in The Research Centre for Respiratory Pathologies (French acronym“CEPR”). This multidisciplinary academic laboratory is located on the campus of the Faculty of Medicine and the university hospital Bretonneau.
Unither Pharmaceuticals is a global development and contract manufacturing organisation specialising in single-unit doses. The company's technology offering includes blow-fill-seal, liquid stick-packs, powder stick-packs, tablets, pharmaceutical bottles, suppositories and pessaries.
Upperton Pharma Solutions is a specialist CDMO offering early feasibility studies, process optimisation, scale-up and clinical trial (GMP) manufacturing. In addition to formulation work it offers a range of analytical services. The company’s core expertise is in spray drying technology.
URSATEC develops preservative-free applications based on its proprietary packaging systems in different areas, primarily the nasal, dermal, buccal and otological fields. The company offers full development services, dosage systems, primary packaging materials and filling services.
USAMRIID is the US Department of Defense's lead laboratory for medical and biological defence R&D. USAMRIID develops medical solutions, including vaccines, drugs, diagnostics, and information, to protect US military service members and respond to public health threats.
Validose's technology platform is a smart, intranasal medical device that uses biometric analysis to limit and control the dosage of controlled substances, which have the ability to treat a wide variety of medical conditions but may have a high potential for addiction and abuse.
Validus Engineering specialises in numerical simulation within finite element analysis, CFD and multiphysics, to include structural, thermal, fluid flow, particle and electromagnetic simulations. Areas of expertise include respiratory delivery, moisture ingress and desiccants and bolus injection.
Vectura is a specialist inhalation CDMO providing innovative inhaled drug delivery solutions. With differentiated proprietary technology and pharmaceutical development expertise, Vectura applies extensive device, formulation and development capabilities.
Vetter is a global CDMO with services ranging from early-stage development support, including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges, including complete aseptic fill and finish services.
Victrex is a supplier of high-performance polymers, focusing on the aerospace, automotive, energy, electronics, manufacturing & engineering, and medical markets. Victrex PEEK and PAEK polymers have multiple applications in drug delivery, including for devices such as inhalers and wearable injectors.
Visionisti is is developing a patented platform for precise and simple delivery of drugs to the suprachoroidal space of the eye using standard commercially available needles. Visionisti was established in 2014 and is seeking partners for the commercialisation of its technology.
Voluntis, an Aptar Pharma company, creates digital therapeutics that combine mobile and web apps, and use clinical algorithms to deliver personalised recommendations to patients and their care teams. For example, these recommendations are used to adjust treatment dosage, manage side effects or monitor symptoms.
Vivera Pharmaceuticals has global exclusivity to license the TABMELT sublingual delivery system for pharmaceutical use. It has its own issued patents on ZICOH, a smart dose-controlled medical device, and portable telemedicine station MDZone.
Weibel CDS is a Swiss medical technology company that specialises in research and development of patch injection systems and devices for the delivery of parenteral drugs. The company offers solutions in filling, production and customisation of its device product lines.
Weidmann Medical Technology is an injection moulding company serving the medical device and pharma industry, focusing on the development of innovative, technically advanced injection-moulded components, including for pharmaceutical primary packaging and drug delivery devices.
Part of Purdue University, The Weldon School of Biomedical Engineering has recognised education and translational research programmes. It fosters strong academic, industrial and clinical ties that promote experiential learning and technology development. It has started >25 companies.
West Pharmaceutical Services designs and manufactures drug delivery and pharmaceutical packaging systems for injectable medicines. The company's products include prefillable syringes, autoinjectors and wearable injectors. West also offers analytical and contract manufacturing services.
Windgap Medical offers autoinjector platforms for difficult-to-mix drugs, freeing patients, families and potential treatments from the limitations of current technology. Its first product is for the administration of adrenaline for anaphylaxis, with additional products under development.
The Woolcock Institute of Medical Research is a not-for-profit research institute focusing on respiratory and sleep research. Its main areas of research are: respiratory disease, sleep disorders and lung cancer. It conducts research into respiratory drug delivery that is highly regarded across the industry.
WuXi AppTec provides R&D and manufacturing services including chemistry drug contract research, development and manufacturing organisation services; biology discovery; preclinical testing and clinical research services; and cell and gene therapy contract testing, development and manufacturing.
Xeris Pharmaceuticals is a specialty pharmaceutical company that leverages novel formulation technology platforms to develop and commercialise ready-to-use liquid-stable injectables. The company is focused on creating medicines that are easier to use, including its Gvoke® glucagon injection.
Ximedica is a full-service design and development firm with an exclusive focus on medical devices, combination products and consumer health. Its drug delivery expertise includes topical, transmucosal, inhalation, and injection. It is ISO 13485:2016 certified and US FDA registered.
Yole Group is a market research and strategy consulting company. As well as consulting and marketing services, Yole produces markets analysis reports of various technology sectors, including on topics such as connected healthcare and medical devices.
Ypsomed is a medical technology company that specialises in drug delivery devices for self-injection, under the Yposmed Delivery Systems brand, and products for diabetic patients, under the mylife Diabetescare brand. Ypsomed develops a range of autoinjector, pen injector and wearable injector platforms.
ZAHORANSKY is a designer and supplier of machinery, production lines, injection moulds and automation equipment. ZAHORANSKY develops and manufactures a range of modular automation technologies, including for sterile primary packaging for pharmaceuticals.